0001209191-23-050295.txt : 20230921
0001209191-23-050295.hdr.sgml : 20230921
20230921165713
ACCESSION NUMBER: 0001209191-23-050295
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230920
FILED AS OF DATE: 20230921
DATE AS OF CHANGE: 20230921
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Iadonato Shawn
CENTRAL INDEX KEY: 0001958184
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37695
FILM NUMBER: 231269617
MAIL ADDRESS:
STREET 1: C/O KINETA, INC.
STREET 2: 219 TERRY AVE. N., SUITE 300
CITY: SEATTLE
STATE: WA
ZIP: 98109
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: KINETA, INC./DE
CENTRAL INDEX KEY: 0001445283
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 219 TERRY AVE. N.
STREET 2: SUITE 300
CITY: SEATTLE
STATE: WA
ZIP: 98109
BUSINESS PHONE: (206) 378-0400
MAIL ADDRESS:
STREET 1: 219 TERRY AVE. N.
STREET 2: SUITE 300
CITY: SEATTLE
STATE: WA
ZIP: 98109
FORMER COMPANY:
FORMER CONFORMED NAME: YUMANITY THERAPEUTICS, INC.
DATE OF NAME CHANGE: 20201223
FORMER COMPANY:
FORMER CONFORMED NAME: PROTEOSTASIS THERAPEUTICS, INC.
DATE OF NAME CHANGE: 20140813
FORMER COMPANY:
FORMER CONFORMED NAME: PROTEOSTASIS THERAPEUTICS INC
DATE OF NAME CHANGE: 20080916
4
1
doc4.xml
FORM 4 SUBMISSION
X0508
4
2023-09-20
0
0001445283
KINETA, INC./DE
KA
0001958184
Iadonato Shawn
C/O KINETA, INC.
219 TERRY AVE. N., SUITE 300
SEATTLE
WA
98109
1
1
0
0
Chief Executive Officer
0
Common Stock
2023-09-20
4
P
0
10000
2.5042
A
670230
D
Common Stock
8553
I
By IRA
The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $2.455 to $2.580, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
/s/ Pauline Kenny, as Attorney-in-Fact
2023-09-21